Form 4 for ONC BeOne Medicines Ltd.
Accepted 2026-08-05 17:15:58 ET · period of report 2026-08-03 · accession 0002031182-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 17:15 | 2026-08-03 | ONC | Rosenberg Aaron | CFO | S - Sale | $312.71 | -1,157 | 0 | -100% | -$361.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-08-03 | S | D | 1,157 | $312.71 | 0 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F2) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |